“Clearly the p value in severe is going to be ex
Post# of 148293
(Total Views: 422)
Posted On: 08/12/2020 9:11:12 AM
“Clearly the p value in severe is going to be excellent.”
100% agree. The results from the small M2M trial indicate that the interim analysis of the severe trial will show a clear benefit in the leronlimab group. I hope that the severe trial is near 195 patients and we should get an update on the CC today.
100% agree. The results from the small M2M trial indicate that the interim analysis of the severe trial will show a clear benefit in the leronlimab group. I hope that the severe trial is near 195 patients and we should get an update on the CC today.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼